Micronutrient-gene interactions related to inflammatory/immune response and antioxidant activity in ageing and inflammation. A systematic review

Mechanisms of Ageing and Development

Volumn 136-137, Issue , 2014, Pages 29-49

  Mocchegiani, Eugenio ^a   Costarelli, Laura ^a   Giacconi, Robertina ^a   Malavolta, Marco ^a   Basso, Andrea ^a   Piacenza, Francesco ^a   Ostan, Rita ^b   Cevenini, Elisa ^b   Gonos, Efstathios S ^c   Monti, Daniela ^d  

^a INRCA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INSTITUTE OF BIOLOGY   (Greece)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Ageing; Antioxidant activity; Immune system; Longevity; Zinc copper selenium gene interactions

Indexed keywords

COPPER; METALLOTHIONEIN; SELENIUM; TRACE ELEMENT; ZINC; ANTIOXIDANT; CHELATING AGENT;

ABSORPTION; AGING; ANTIOXIDANT ACTIVITY; ARTICLE; CHELATION; DIETARY INTAKE; GENE INTERACTION; GERIATRIC DISORDER; HEALTH STATUS; HEREDITY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; LONGEVITY; NONHUMAN; NUTRIGENOMICS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TASK PERFORMANCE; AGED; BLOOD; CHEMISTRY; DEFICIENCY; DIET SUPPLEMENTATION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; TOXICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; CHELATING AGENTS; COPPER; DIETARY SUPPLEMENTS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LONGEVITY; MICRONUTRIENTS; NUTRIGENOMICS; SELENIUM; ZINC;

EID: 84899991551     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2013.12.007     Document Type: Article

References (293)

1. Akbaraly N.T., Arnaud J., Hininger-Favier I., Gourlet V., Roussel A.M., Berr C. Selenium and mortality in the elderly: results from the EVA study. Clinical Chemistry 2005, 51:2117-2123.
2. Akbaraly T.N., Hininger-Favier I., Carriere I., Arnaud J., Gourlet V., Roussel A.M., Berr C. Plasma selenium over time and cognitive decline in the elderly. Epidemiology 2007, 18:52-58.
3. Akbaraly T.N., Arnaud J., Rayman M.P., Hininger-Favier I., Roussel A.M., Berr C., Fontbonne A. Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutrition and Metabolism 2010, 7. 21-7075-27.
4. Alanne M., Kristiansson K., Auro K., Silander K., Kuulasmaa K., Peltonen L., Salomaa V., Perola M. Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts. Human Genetics 2007, 122(3-4):355-365.
5. Alberti S., Cevenini E., Ostan R., Capri M., Salvioli S., Bucci L., Ginaldi L., De Martinis M., Franceschi C., Monti D. Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans. Mechanisms of Ageing and Development 2006, 127:560-566.
6. Alberts M.J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A.M., Roses A.D. ApoE genotype and survival from intracerebral haemorrhage. Lancet 1995, 346:575.
7. Alvarez Leon E., Henriquez P., Serra-Majem L. Mediterranean diet and metabolic syndrome: a cross-sectional study in the Canary Islands. Public Health Nutrition 2006, 9:1089-1098.
8. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17589-17594.
9. Anantharaju A., Feller A., Chedid A. Aging liver. A review. Gerontology 2002, 48:343-353.
10. Andree K.B., Kim J., Kirschke C.P., Gregg J.P., Paik H., Joung H., Woodhouse L., King J.C., Huang L. Investigation of lymphocyte gene expression for use as biomarkers for zinc state in humans. The Journal of Nutrition 2004, 134:1716-1723.
11. Andreini C., Bertini I. A bioinformatics view of zinc enzymes. Journal of Inorganic Biochemistry 2012, 111:150-156.
12. Andrews G.K. Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals 2001, 14:223-237.
13. AREDS (Age-Related Eye Disease Study Research Group) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology 2001, 119:1417-1436.
14. Arnaud J., Akbaraly T.N., Hininger I., Roussel A.M., Berr C. Factors associated with longitudinal plasma selenium decline in the elderly: the EVA study. The Journal of Nutritional Biochemistry 2007, 18:482-487.
15. Aro A., Alfthan G., Varo P. Effects of supplementation of fertilizers on human selenium status in Finland. The Analyst 1995, 120:841-843.
16. Arredondo M., Munoz P., Mura C.V., Nunez M.T. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. American Journal of Physiology Cell Physiology 2003, 284:C1525-C1530.
17. Bala S., Failla M.L. Copper deficiency reversibly impairs DNA synthesis in activated T lymphocytes by limiting interleukin 2 activity. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:6794-6797.
18. Bao B., Prasad A.S., Beck F.W., Fitzgerald J.T., Snell D., Bao G.W., Singh T., Cardozo L.J. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. The American Journal of Clinical Nutrition 2010, 91:1634-1641.
19. Bareggi S.R., Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neuroscience and Therapeutics 2012, 18:41-46.
20. Bayer T.A., Schafer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schussel K., Eikenberg O., Sturchler-Pierrat C., Abramowski D., Staufenbiel M., Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:14187-14192.
21. Beck M.A. Selenium and host defence towards viruses. The Proceedings of the Nutrition Society 1999, 58:707-711.
22. Beck M.A., Kolbeck P.C., Rohr L.H., Shi Q., Morris V.C., Levander O.A. Benign human enterovirus becomes virulent in selenium-deficient mice. Journal of Medical Virology 1994, 43:166-170.
23. Beck F.W., Prasad A.S., Kaplan J., Fitzgerald J.T., Brewer G.J. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. The American Journal of Physiology 1997, 272:E1002-E1007.
24. Beck M.A., Esworthy R.S., Ho Y.S., Chu F.F. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB Journal 1998, 12:1143-1149.
25. Behne D., Hammel C., Pfeifer H., Rothlein D., Gessner H., Kyriakopoulos A. Speciation of selenium in the mammalian organism. The Analyst 1998, 123:871-873.
26. Bermano G., Pagmantidis V., Holloway N., Kadri S., Mowat N.A., Shiel R.S., Arthur J.R., Mathers J.C., Daly A.K., Broom J., Hesketh J.E. Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes and Nutrition 2007, 2:225-232.
27. Bleys J., Navas-Acien A., Guallar E. Serum selenium and diabetes in US adults. Diabetes Care 2007, 30:829-834.
28. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S.M., Li B. The Linxian trials: mortality rates by vitamin-mineral intervention group. The American Journal of Clinical Nutrition 1995, 62:1424S-1426S.
29. Bonham M., O'Connor J.M., Hannigan B.M., Strain J.J. The immune system as a physiological indicator of marginal copper status?. The British Journal of Nutrition 2002, 87:393-403.
30. Bossy-Wetzel E., Talantova M.V., Lee W.D., Scholzke M.N., Harrop A., Mathews E., Gotz T., Han J., Ellisman M.H., Perkins G.A., Lipton S.A. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004, 41:351-365.
31. Brewer G.J. Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease. Experimental Biology and Medicine 2007, 232:323-335.
32. Brewer G.J. The risks of free copper in the body and the development of useful anticopper drugs. Current Opinion in Clinical Nutrition and Metabolic Care 2008, 11:727-732.
33. Brewer G.J., Askari F., Dick R.B., Sitterly J., Fink J.K., Carlson M., Kluin K.J., Lorincz M.T. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Translational Research 2009, 154:70-77.
34. Brigelius-Flohe R., Banning A. Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer. Free Radical Research 2006, 40:775-787.
35. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genetics 1993, 5:327-337.
36. Bush A.I. Metals and neuroscience. Current Opinion in Chemical Biology 2000, 4:184-191.
37. Camakaris J., Danks D.M., Ackland L., Cartwright E., Borger P., Cotton R.G. Altered copper metabolism in cultured cells from human Menkes' syndrome and mottled mouse mutants. Biochemical Genetics 1980, 18:117-131.
38. Casadei M., Persichini T., Polticelli F., Musci G., Colasanti M. s-Glutathionylation of metallothioneins by nitrosative/oxidative stress. Experimental Gerontology 2008, 43:415-422.
39. Chasapis C.T., Loutsidou A.C., Spiliopoulou C.A., Stefanidou M.E. Zinc and human health: an update. Archives of Toxicology 2012, 86:521-534.
40. Chernoff R. Nutrition and health promotion in older adults. The Journals of Gerontology Series A 2001, 56(Spec. no. 2):47-53.
41. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y., Huang X., Goldstein L.E., Moir R.D., Lim J.T., Beyreuther K., Zheng H., Tanzi R.E., Masters C.L., Bush A.I. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 2001, 30:665-676.
42. Chiricolo M., Musa A.R., Monti D., Zannotti M., Franceschi C. Enhanced DNA repair in lymphocytes of Down syndrome patients: the influence of zinc nutritional supplementation. Mutation Research 1993, 295:105-111.
43. Chow C.K. Nutritional influence on cellular antioxidant defense systems. The American Journal of Clinical Nutrition 1979, 32:1066-1081.
44. Cipriano C., Malavolta M., Costarelli L., Giacconi R., Muti E., Gasparini N., Cardelli M., Monti D., Mariani E., Mocchegiani E. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 2006, 7:357-365.
45. The Role of Selenium in Nutrition 1986, 1-210. Academic Press, San Diego, CA, USA. G.F. Combs, S.B. Combs (Eds.).
46. Cooper G.J., Phillips A.R., Choong S.Y., Leonard B.L., Crossman D.J., Brunton D.H., Saafi, Dissanayake A.M., Cowan B.R., Young A.A., Occleshaw C.J., Chan Y.K., Leahy F.E., Keogh G.F., Gamble G.D., Allen G.R., Pope A.J., Boyd P.D., Poppitt S.D., Borg T.K., Doughty R.N., Baker J.R. Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004, 53:2501-2508.
47. Cooper M.L., Adami H.O., Gronberg H., Wiklund F., Green F.R., Rayman M.P. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Research 2008, 68:10171-10177.
48. Cossack Z.T. T-lymphocyte dysfunction in the elderly associated with zinc deficiency and subnormal nucleoside phosphorylase activity: effect of zinc supplementation. European Journal of Cancer and Clinical Oncology 1989, 25:973-976.
49. Cousins R.J. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiological Reviews 1985, 65:238-309.
50. Cousins R.J. Toward a molecular understanding of zinc metabolism. Clinical Physiology and Biochemistry 1986, 4:20-30.
51. Cousins R.J. A role of zinc in the regulation of gene expression. The Proceedings of the Nutrition Society 1998, 57:307-311.
52. Coyle P., Philcox J.C., Carey L.C., Rofe A.M. Metallothionein: the multipurpose protein. Cellular and Molecular Life Sciences 2002, 59:627-647.
53. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., Bush A.I. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. The Journal of Biological Chemistry 2000, 275:19439-19442.
54. Culotta V.C., Lin S.J., Schmidt P., Klomp L.W., Casareno R.L., Gitlin J. Intracellular pathways of copper trafficking in yeast and humans. Advances in Experimental Medicine and Biology 1999, 448:247-254.
55. Curran J.E., Jowett J.B., Elliott K.S., Gao Y., Gluschenko K., Wang J., Abel Azim D.M., Cai G., Mahaney M.C., Comuzzie A.G., Dyer T.D., Walder K.R., Zimmet P., MacCluer J.W., Collier G.R., Kissebah A.H., Blangero J. Genetic variation in selenoprotein S influences inflammatory response. Nature Genetics 2005, 37:1234-1241.
56. Czernichow S., Bertrais S., Blacher J., Galan P., Briancon S., Favier A., Safar M., Hercberg S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. Journal of Hypertension 2005, 23:2013-2018.
57. Dancis A., Haile D., Yuan D.S., Klausner R.D. The Saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake. The Journal of Biological Chemistry 1994, 269:25660-25667.
58. Danks D.M. Copper deficiency in humans. Annual Review of Nutrition 1988, 8:235-257.
59. Danzeisen R., Araya M., Harrison B., Keen C., Solioz M., Thiele D., McArdle H.J. How reliable and robust are current biomarkers for copper status?. The British Journal of Nutrition 2007, 98:676-683.
60. Darnton-Hill I., Margetts B., Deckelbaum R. Public health nutrition and genetics: implications for nutrition policy and promotion. The Proceedings of the Nutrition Society 2004, 63:173-185.
61. Das H., Kumar A., Lin Z., Patino W.D., Hwang P.M., Feinberg M.W., Majumder P.K., Jain M.K. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6653-6658.
62. Delerive P., Gervois P., Fruchart J.C., Staels B. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. The Journal of Biological Chemistry 2000, 275:36703-36707.
63. Delmi M., Rapin C.H., Bengoa J.M., Delmas P.D., Vasey H., Bonjour J.P. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet 1990, 335:1013-1016.
64. Dreher I., Jakobs T.C., Kohrle J. Cloning and characterization of the human selenoprotein P promoter. Response of selenoprotein P expression to cytokines in liver cells. The Journal of Biological Chemistry 1997, 272:29364-29371.
65. Duchateau J., Delepesse G., Vrijens R., Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. The American Journal of Medicine 1981, 70:1001-1004.
66. El Balkhi S., Poupon J., Trocello J.M., Massicot F., Woimant F., Laprévote O. Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection. Analitical Chemistry 2010, 82:6904-6910.
67. Ellis S.E., Coffey C.S., Mitchel E.F., Dittus R.S., Griffin M.R. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. Journal of the American Geriatrics Society 2003, 51:761-767.
68. El-Omar E.M., Chow W.H., Rabkin C.S. Gastric cancer and H. pylori: host genetics open the way. Gastroenterology 2001, 121:1002-1004.
69. Enbergs A., Dorszewski A., Luft M., Monnig G., Kleemann A., Schulte H., Assmann G., Breithardt G., Kerber S. Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis. Coronary Artery Disease 1998, 9:119-124.
70. Erie J.C., Good J.A., Butz J.A., Pulido J.S. Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration. American Journal of Ophthalmology 2009, 147:276-282.e1.
71. Erusalimsky J.D., Kurz D.J. Endothelial cell senescence. Handbook of Experimental Pharmacology 2006, 176(Pt 2):213-248.
72. Failla M.L. Trace elements and host defense: recent advances and continuing challenges. The Journal of Nutrition 2003, 133:1443S-1447S.
73. Fan A.M., Kizer K.W. Selenium. Nutritional, toxicologic, and clinical aspects. The Western Journal of Medicine 1990, 153:160-167.
74. Faure P., Ramon O., Favier A., Halimi S. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. European Journal of Clinical Investigation 2004, 34:475-481.
75. Ferns G.A., Lamb D.J., Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis 1997, 133:139-152.
76. Festa R.A., Thiele D.J. Copper: an essential metal in biology. Current Biology 2011, 21:R877-R883.
77. Ford E.S. Serum copper concentration and coronary heart disease among US adults. American Journal of Epidemiology 2000, 151:1182-1188.
78. Forsberg L., de Faire U., Marklund S.L., Andersson P.M., Stegmayr B., Morgenstern R. Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells, Molecules and Diseases 2000, 26:423-426.
79. Fox P.L., Mazumder B., Ehrenwald E., Mukhopadhyay C.K. Ceruloplasmin and cardiovascular disease. Free Radical Biology and Medicine 2000, 28:1735-1744.
80. Fraker P.J., King L.E. A distinct role for apoptosis in the changes in lymphopoiesis and myelopoiesis created by deficiencies in zinc. FASEB Journal 2001, 15:2572-2578.
81. Fraker P.J., King L.E. Reprogramming of the immune system during zinc deficiency. Annual Review of Nutrition 2004, 24:277-298.
82. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured?. Nutrition Review 2007, 65:S173-S176.
83. Franceschi C., Chiricolo M., Licastro F., Zannotti M., Masi M., Mocchegiani E., Fabris N. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects. Journal of Mental Deficiency Research 1988, 32(Pt 3):169-181.
84. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 2000, 908:244-254.
85. Frazzini V., Rockabrand E., Mocchegiani E., Sensi S.L. Oxidative stress and brain aging: is zinc the link?. Biogerontology 2006, 7:307-314.
86. Frederickson C.J., Burdette S.C., Frederickson C.J., Sensi S.L., Weiss J.H., Yin H.Z., Balaji R.V., Truong-Tran A.Q., Bedell E., Prough D.S., Lippard S.J. Method for identifying neuronal cells suffering zinc toxicity by use of a novel fluorescent sensor. Journal of Neuroscience Medicine 2004, 139:79-89.
87. 2: is there a potential effect of copper?. Journal of Inherited Metabolic Disease 2004, 27:67-79.
88. Fukuyama S., Matsunaga Y., Zhanghui W., Noda N., Asai Y., Moriwaki A., Matsumoto T., Nakano T., Matsumoto K., Nakanishi Y., Inoue H. A zinc chelator TPEN attenuates airway hyper responsiveness and airway inflammation in mice in vivo. Allergology International 2011, 60:259-266.
89. Fulop T., Larbi A., Dupuis G., Pawelec G. Ageing, autoimmunity and arthritis: perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Research and Therapy 2003, 5:290-302.
90. Funseth E., Lindh U., Wesslen L., Friman G., Ilback N.G. Trace element changes in the myocardium during coxsackievirus B3 myocarditis in the mouse. Biological Trace Element Research 2000, 76:149-160.
91. Gao Y., Hannan N.R., Wanyonyi S., Konstantopolous N., Pagnon J., Feng H.C., Jowett J.B., Kim K.H., Walder K., Collier G.R. Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 2006, 33:246-251.
92. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., Gasparini N., Malavolta M., Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005, 6:407-413.
93. Giacconi R., Bonfigli A.R., Testa R., Sirolla C., Cipriano C., Marra M., Muti E., Malavolta M., Costarelli L., Piacenza F., Tesei S., Mocchegiani E. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Molecular Genetics and Metabolism 2008, 94:98-104.
94. Giacconi R., Muti E., Malavolta M., Cardelli M., Pierpaoli S., Cipriano C., Costarelli L., Tesei S., Saba V., Mocchegiani E. A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging. Rejuvenation Research 2008, 11:297-300.
95. Giacconi R., Kanoni S., Mecocci P., Malavolta M., Richter D., Pierpaoli S., Costarelli L., Cipriano C., Muti E., Mangialasche F., Piacenza F., Tesei S., Galeazzi R., Theodoraki E.V., Lattanzio F., Dedoussis G., Mocchegiani E. Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort. The Journal of Nutritional Biochemistry 2010, 21:1008-1014.
96. Girodon F., Galan P., Monget A.L., Boutron-Ruault M.C., Brunet-Lecomte P., Preziosi P., Arnaud J., Manuguerra J.C., Herchberg S. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Archives of Internal Medicine 1999, 159:748-754.
97. Gojová L., Jansova E., Kulm M., Pouchla S., Kozak L. Genotyping microarray as a novel approach for the detection of ATP7B gene mutations in patients with Wilson disease. Clinical Genetics 2008, 73:441-452.
98. Golovine K., Uzzo R.G., Makhov P., Crispen P.L., Kunkle D., Kolenko V.M. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Prostate 2008, 68:1443-1449.
99. Gonzalez S., Huerta J.M., Fernandez S., Patterson A.M., Lasheras C. Life-quality indicators in elderly people are influenced by selenium status. Aging Clinical and Experimental Research 2007, 19:10-15.
100. Guo C.H., Wang C.L. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. International Journal of Medical Sciences 2013, 10:79-89.
101. Haase H., Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annual Review of Nutrition 2009, 29:133-152.
102. Haase H., Rink L. The immune system and the impact of zinc during aging. Immunity and Ageing 2009, 6:6-9.
103. Haase H., Ober-Blobaum J.L., Engelhardt G., Hebel S., Heit A., Heine H., Rink L. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. Journal of Immunology 2008, 181:6491-6502.
104. Hamza I., Faisst A., Prohaska J., Chen J., Gruss P., Gitlin J.D. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6848-6852.
105. Hamza I., Prohaska J., Gitlin J.D. Essential role for Atox1 in the copper-mediated intracellular trafficking of the Menkes ATPase. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:1215-1220.
106. Hartmann H.J., Felix K., Nagel W., Weser U. Intestinal administration of copper and its transient release into venous rat blood serum concomitantly with metallothionein. Biometals 1993, 6:115-118.
107. Harvey L.J., Majsak-Newman G., Dainty J.R., Lewis D.J., Langford N.J., Crews H.M., Fairweather-Tait S.J. Adaptive responses in men fed low- and high-copper diets. The British Journal of Nutrition 2003, 90:161-168.
108. Harvey L.J., Ashton K., Hooper L., Casgrain A., Fairweather-Tait S.J. Methods of assessment of copper status in humans: a systematic review. The American Journal of Clinical Nutrition 2009, 89:2009S-2024S.
109. Hatfield D.L., Gladyshev V.N. How selenium has altered our understanding of the genetic code. Molecular and Cellular Biology 2002, 22:3565-3576.
110. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
111. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radical Research 1999, 31:273-300.
112. Hesketh J. Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annual Review of Nutrition 2008, 28:157-177.
113. Hesketh J., Meplan C. Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: focus on selenium as an exemplar. The Proceedings of the Nutrition Society 2011, 70:1-9.
114. Hopkins R.G., Failla M.L. Transcriptional regulation of interleukin-2 gene expression is impaired by copper deficiency in Jurkat human T lymphocytes. The Journal of Nutrition 1999, 129:596-601.
115. Hu Y.J., Diamond A.M. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Research 2003, 63:3347-3351.
116. Hu Y.J., Korotkov K.V., Mehta R., Hatfield D.L., Rotimi C.N., Luke A., Prewitt T.E., Cooper R.S., Stock W., Vokes E.E., Dolan M.E., Gladyshev V.N., Diamond A.M. Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 gene. Cancer Research 2001, 61:2307-2310.
117. Ichimura Y., Habuchi T., Tsuchiya N., Wang L., Oyama C., Sato K., Nishiyama H., Ogawa O., Kato T. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. The Journal of Urology 2004, 172:728-732.
118. Jablonska E., Gromadzinska J., Sobala W., Reszka E., Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. European Journal of Nutrition 2008, 47:47-54.
119. Jiang Y., Reynolds C., Xiao C., Feng W., Zhou Z., Rodriguez W., Tyagi S.C., Eaton J.W., Saari J.T., Kang Y.J. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. The Journal of Experimental Medicine 2007, 204:657-666.
120. Kabu K., Yamasaki S., Kamimura D., Ito Y., Hasegawa A., Sato E., Kitamura H., Nishida K., Hirano T. Zinc is required for Fc epsilon RI-mediated mast cell activation. Journal of Immunology 2006, 177:1296-1305.
121. Kahmann L., Uciechowski P., Warmuth S., Plumakers B., Gressner A.M., Malavolta M., Mocchegiani E., Rink L. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Research 2008, 11:227-237.
122. Kaler S.G. Menkes disease. Advances in Pediatrics 1994, 41:263-304.
123. Kant A.K. Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988-1994. The American Journal of Clinical Nutrition 2000, 72:929-936.
124. Kato K., Oguri M., Kato N., Hibino T., Yajima K., Yoshida T., Metoki N., Yoshida H., Satoh K., Watanabe S., Yokoi K., Murohara T., Yamada Y. Assessment of genetic risk factors for thoracic aortic aneurysm in hypertensive patients. American Journal of Hypertension 2008, 21:1023-1027.
125. Kelley D.S., Daudu P.A., Taylor P.C., Mackey B.E., Turnlund J.R. Effects of low-copper diets on human immune response. The American Journal of Clinical Nutrition 1995, 62:412-416.
126. Kelner G.S., Lee M., Clark M.E., Maciejewski D., McGrath D., Rabizadeh S., Lyons T., Bredesen D., Jenner P., Maki R.A. The copper transport protein Atox1 promotes neuronal survival. The Journal of Biological Chemistry 2000, 275:580-584.
127. Khatai L., Goessler W., Lorencova H., Zangger K. Modulation of nitric oxide-mediated metal release from metallothionein by the redox state of glutathione in vitro. European Journal of Biochemistry 2004, 271:2408-2416.
128. Kim Y.S., Milner J. Molecular targets for selenium in cancer prevention. Nutrition and Cancer 2001, 40:50-54.
129. Kim C.H., Park J.Y., Kim J.Y., Choi C.S., Kim Y.I., Chung Y.E., Lee M.S., Hong S.K., Lee K.U. Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. Metabolism: Clinical and Experimental 2002, 51:838-842.
130. Kipp A., Banning A., van Schothorst E.M., Meplan C., Schomburg L., Evelo C., Coort S., Gaj S., Keijer J., Hesketh J., Brigelius-Flohe R. Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon. Molecular Nutrition and Food Research 2009, 53:1561-1572.
131. Kirchman P.A., Botta G. Copper supplementation increases yeast life span under conditions requiring respiratory metabolism. Mechanisms of Ageing and Development 2007, 128:187-195.
132. Klevay L.M. Cardiovascular disease from copper deficiency - a history. The Journal of Nutrition 2000, 130:489S-492S.
133. Klipstein-Grobusch K., Grobbee D.E., Koster J.F., Lindemans J., Boeing H., Hofman A., Witteman J.C. Serum caeruloplasmin as a coronary risk factor in the elderly: the Rotterdam Study. The British Journal of Nutrition 1999, 81:139-144.
134. Klug A. Zinc finger peptides for the regulation of gene expression. Journal of Molecular Biology 1999, 293:215-218.
135. Krajacic P., Qian Y., Hahn P., Dentchev T., Lukinova N., Dunaief J.L. Retinal localization and copper-dependent relocalization of the Wilson and Menkes disease proteins. Investigative Ophthalmology and Visual Science 2006, 47:3129-3134.
136. Kreuder J., Otten A., Fuder H., Tümer Z., Tønnesen T., Horn N., Dralle D. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease. European Journal of Pediatrics 1993, 152:828-832.
137. Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guigo R., Gladyshev V.N. Characterization of mammalian selenoproteomes. Science 2003, 300:1439-1443.
138. Kury S., Dreno B., Bezieau S., Giraudet S., Kharfi M., Kamoun R., Moisan J.P. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nature Genetics 2002, 31:239-240.
139. Lalioti V., Muruais G., Tsuchiya Y., Pulido D., Sandoval I.V. Molecular mechanisms of copper homeostasis. Frontiers in Bioscience 2009, 14:4878-4903.
140. Lansdown A.B., Mirastschijski U., Stubbs N., Scanlon E., Agren M.S. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair and Regeneration 2007, 15:2-16.
141. Lee P.L., Gelbart T., West C., Halloran C., Felitti V., Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells, Molecules and Diseases 2001, 27:783-802.
142. Lee J.Y., Kim J.H., Palmiter R.D., Koh J.Y. Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Experimental Neurology 2003, 184:337-347.
143. Li Q., Liu M., Hou J., Jiang C., Li S., Wang T. The prevalence of Keshan disease in China. International Journal of Cardiology 2013, 168:1121-1126.
144. Linder M.C., Hazegh-Azam M. Copper biochemistry and molecular biology. The American Journal of Clinical Nutrition 1996, 63:797S-811S.
145. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L., Parnes G., Minasian H.L., Gaziano L.M., Hartline J.M., Parsons J.A., Bearden J.K., Crawford J.D., Goodman E.D., Claudio G.E., Winquist J., Cook E., Karp E.D., Walther D.D., Lieber P., Kristal M.M., Darke A.R., Arnold A.K., Ganz K.B., Santella P.A., Albanes R.M., Taylor D., Probstfield P.R., Jagpal J.L., Crowley T.J., Meyskens J.J., Baker F.L., Coltman L.H.C.A. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). The Journal of the American Medical Association 2009, 301:39-51.
146. Liu J., Atamna H., Kuratsune H., Ames B.N. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Annals of the New York Academy of Sciences 2002, 959:133-166.
147. Llanos R.M., Mercer J.F. The molecular basis of copper homeostasis copper-related disorders. DNA and Cell Biology 2002, 21:259-270.
148. Lowe N.M., Lowe N.M., Fraser W.D., Jackson M.J. Is there a potential therapeutic value of copper and zinc for osteoporosis?. The Proceedings of the Nutrition Society 2002, 61:181-185.
149. Lutsenko S., Petris M.J. Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches. The Journal of Membrane Biology 2003, 191:1-12.
150. Lyons T.J., Nersissian A., Huang H., Yeom H., Nishida C.R., Graden J.A., Gralla E.B., Valentine J.S. The metal binding properties of the zinc site of yeast copper-zinc superoxide dismutase: implications for amyotrophic lateral sclerosis. Journal of Biological Inorganic Chemistry 2000, 5:189-203.
151. Mackay J.P., Crossley M. Zinc fingers are sticking together. Trends in Biochemical Science 1998, 23:1-4.
152. Madarić A., Ginter E., Kadrabová J. Serum copper, zinc and copper/zinc ratio in males: influence of aging. Physiological Research 1994, 43:107-111.
153. Maggini S., Wintergerst E.S., Beveridge S., Hornig D.H. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. The British Journal of Nutrition 2007, 98(Suppl 1):S29-S35.
154. Malavolta M., Giacconi R., Piacenza F., Santarelli L., Cipriano C., Costarelli L., Tesei S., Pierpaoli S., Basso A., Galeazzi R., Lattanzio F., Mocchegiani E. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology 2010, 11:309-319.
155. Malavolta M., Piacenza F., Basso A., Giacconi R., Costarelli L., Pierpaoli S., Mocchegiani E. Speciation of trace elements in human serum by micro anion exchange chromatography coupled with inductively coupled plasma mass spectrometry. Analytical Biochemistry 2012, 421:16-25.
156. Mao X., Schimmer A.D. The toxicology of Clioquinol. Toxicology Letters 2008, 182:1-6.
157. Marcellini F., Giuli C., Papa R., Gagliardi C., Dedoussis G., Monti D., Jajte J., Giacconi R., Malavolta M., Mocchegiani E. Zinc in elderly people: effects of zinc supplementation on psychological dimensions in dependence of IL-6 -174 polymorphism: a Zincage study. Rejuvenation Research 2008, 11:479-483.
158. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. The Journal of Nutrition 2003, 133. 1460S-2S.
159. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxidants and Redox Signalling 2006, 8:1419-1441.
160. Mariani E., Mangialasche F., Feliziani F.T., Cecchetti R., Malavolta M., Bastiani P., Baglioni M., Dedoussis G., Fulop T., Herbein G., Jajte J., Monti D., Rink L., Mocchegiani E., Mecocci P. Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Experimental Gerontology 2008, 43:445-451.
161. Mariani E., Neri S., Cattini L., Mocchegiani E., Malavolta M., Dedoussis G.V., Kanoni S., Rink L., Jajte J., Facchini A. Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and -174 IL-6 polymorphic alleles. Experimental Gerontology 2008, 43:462-471.
162. Martin J.E., Sheaff M.T. Renal ageing. The Journal of Pathology 2007, 211:198-205.
163. Mattie M.D., Freedman J.H. Protective effects of aspirin and vitamin E (alpha-tocopherol) against copper- and cadmium-induced toxicity. Biochemical and Biophysical Research Communications 2001, 285:921-925.
164. Mattson M.P. Dietary factors, hormesis and health. Ageing Research Reviews 2008, 7:43-48.
165. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., Cipriano C., Powell J.R., Mocchegiani E. Differential effects of in vitro zinc treatment on gene expression in peripheral blood mononuclear cells derived from young and elderly individuals. Rejuvenation Research 2007, 10:603-620.
166. Mehdi Y., Hornick J.L., Istasse L., Dufrasne I. Selenium in the environment, metabolism and involvement in body functions. Molecules 2013, 18:3292-3311.
167. Meplan C. Trace elements and ageing, a genomic perspective using selenium as an example. Journal of Trace Elements in Medicine and Biology 2011, 25(Suppl 1):S11-S16.
168. Meplan C., Crosley L.K., Nicol F., Beckett G.J., Howie A.F., Hill K.E., Horgan G., Mathers J.C., Arthur J.R., Hesketh J.E. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB Journal 2007, 21:3063-3074.
169. Meplan C., Crosley L.K., Nicol F., Horgan G.W., Mathers J.C., Arthur J.R., Hesketh J.E. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. The American Journal of Clinical Nutrition 2008, 87:1019-1027.
170. Mercer J.F. The molecular basis of copper-transport diseases. Trends in Molecular Medicine 2001, 7:64-69.
171. El Meskini R., Culotta V.C., Mains R.E., Eipper B.A. Supplying copper to the cuproenzyme peptidylglycine alpha-amidating monooxygenase. The Journal of Biological Chemistry 2003, 278:12278-12284.
172. Meydani M. Nutrition interventions in aging and age-associated disease. Annals of the New York Academy of Science 2001, 928:226L 235.
173. Meyer F., Galan P., Douville P., Bairati I., Kegle P., Bertrais S., Estaquio C., Hercberg S. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. International Journal of Cancer 2005, 116:182-186.
174. Milne D.B. Copper intake and assessment of copper status. The American Journal of Clinical Nutrition 1998, 67:1041S-1045S.
175. Mitchell B.D., Hsueh W.C., King T.M., Pollin T.I., Sorkin J., Agarwala R., Schaffer A.A., Shuldiner A.R. Heritability of life span in the Old Order Amish. American Journal of Medical Genetics 2001, 102:346-352.
176. Mitchell W.A., Meng I., Nicholson S.A., Aspinall R. Thymic output ageing and zinc. Biogerontology 2006, 7:461-470.
177. Mitrou P.N., Kipnis V., Thiebaut A.C., Reedy J., Subar A.F., Wirfalt E., Flood A., Mouw T., Hollenbeck A.R., Leitzmann M.F., Schatzkin A. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Archives of Internal Medicine 2007, 167:2461-2468.
178. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nature Genetics 1996, 14:55-61.
179. Mocchegiani E., Malavolta M. Zinc-gene interaction related to inflammatory/immune response in ageing. Genes and Nutrition 2008, 3:61-75.
180. Mocchegiani E., Giacconi R., Muzzioli M., Cipriano C. Zinc, infections and immunosenescence. Mechanisms of Ageing and Development 2000, 121:21-35.
181. Mocchegiani E., Muzzioli M., Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends in Pharmacological Sciences 2000, 21:205-208.
182. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Experimental Gerontology 2002, 37:349-357.
183. Mocchegiani E., Muzzioli M., Giacconi R., Cipriano C., Gasparini N., Franceschi C., Gaetti R., Cavalieri E., Suzuki H. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mechanisms of Ageing and Development 2003, 124:459-468.
184. Mocchegiani E., Bertoni-Freddari C., Marcellini F., Malavolta M. Brain, aging and neurodegeneration: role of zinc ion availability. Progress in Neurobiology 2005, 75:367-390.
185. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Experimental Gerontology 2006, 41:1094-1107.
186. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., Tesei S., Malavolta M. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mechanisms of Ageing and Development 2006, 127:517-525.
187. Mocchegiani E., Giacconi R., Cipriano C., Costarelli L., Muti E., Tesei S., Giuli C., Papa R., Marcellini F., Mariani E., Rink L., Herbein G., Varin A., Fulop T., Monti D., Jajte J., Dedoussis G., Gonos E.S., Trougakos I.P., Malavolta M. Zinc metallothioneins and longevity - effect of zinc supplementation: Zincage study. Annals of the New York Academy of Sciences 2007, 1119:129-146.
188. Mocchegiani E., Giacconi R., Costarelli L., Muti E., Cipriano C., Tesei S., Pierpaoli S., Giuli C., Papa R., Marcellini F., Gasparini N., Pierandrei R., Piacenza F., Mariani E., Monti D., Dedoussis G., Kanoni S., Herbein G., Fulop T., Rink L., Jajte J., Malavolta M. Zinc deficiency and IL-6 -174G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Experimental Gerontology 2008, 43:433-444.
189. Mocchegiani E., Malavolta M., Muti E., Costarelli L., Cipriano C., Piacenza F., Tesei S., Giacconi R., Lattanzio F. Zinc, metallothioneins and longevity: interrelationships with niacin and selenium. Current Pharmaceutical Design 2008, 14:2719-2732.
190. Mocchegiani E., Giacconi R., Cipriano C., Malavolta M. NK and NKT cells in aging and longevity: role of zinc and metallothioneins. Journal of Clinical Immunology 2009, 29:416-425.
191. Mocchegiani E., Costarelli L., Giacconi R., Piacenza F., Basso A., Malavolta M. Micronutrient (Zn, Cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: implications for treatments. Ageing Research Reviews 2012, 11:297-319.
192. Mocchegiani E., Malavolta M., Lattanzio F., Piacenza F., Basso A., Abbatecola A.M., Russo A., Giovannini S., Capoluongo E., Bustacchini S., Guffanti E.E., Bernabei R., Landi F. Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study). Age 2012, 34:539-552.
193. Mocchegiani E., Costarelli L., Basso A., Giacconi R., Piacenza F., Malavolta M. Metallothioneins, ageing and cellular senescence: a future therapeutic target. Current Pharmaceutical Design 2013, 19:1753-1764.
194. Mocchegiani E., Romeo J., Malavolta M., Costarelli L., Giacconi R., Diaz L.E., Marcos A. Zinc: dietary intake and impact of supplementation on immune function in elderly. Age 2013, 35:839-860.
195. Moroni F., Di Paolo M.L., Rigo A., Cipriano C., Giacconi R., Recchioni R., Marcheselli F., Malavolta M., Mocchegiani E. Interrelationship among neutrophil efficiency, inflammation, antioxidant activity and zinc pool in very old age. Biogerontology 2005, 6:271-281.
196. Moulder K., Steward M.W. Experimental zinc deficiency: effects on cellular responses and the affinity of humoral antibody. Clinical and Experimental Immunology 1989, 77:269-274.
197. Mukhopadhyay C.K., Mazumder B., Lindley P.F., Fox P.L. Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:11546-11551.
198. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 1996, 271:1406-1409.
199. Muñoz C., Rios E., Olivos J., Brunser O., Olivares M. Iron, copper and immunocompetence. British Journal of Nutrition 2007, 98(Suppl 1):S24-S28.
200. Nasi M., Troiano L., Lugli E., Pinti M., Ferraresi R., Monterastelli E., Mussi C., Salvioli G., Franceschi C., Cossarizza A. Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. Aging Cell 2006, 5:167-175.
201. Nawrot T.S., Staessen J.A., Roels H.A., Den Hond E., Thijs L., Fagard R.H., Dominiczak A.F., Struijker-Boudier H.A. Blood pressure and blood selenium: a cross-sectional and longitudinal population study. European Heart Journal 2007, 28:628-633.
202. Nelson T.J., Alkon D.L. Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. The Journal of Biological Chemistry 2005, 280:7377-7387.
203. Nicolas M.G., Fujiki K., Murayama K., Suzuki M.T., Shindo N., Hotta Y., Iwata F., Fujimura T., Yoshikawa Y., Cho F., Kanai A. Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. Experimental Eye Research 1996, 62:399-408.
204. Odumade O.A., Weinreich M.A., Jameson S.C., Hogquist K.A. Krüppel-like factor 2 regulates trafficking and homeostasis of gammadelta T cells. Journal of Immunology 2010, 184:6060-6066.
205. Olivares M., Uauy R. Copper as an essential nutrient. The American Journal of Clinical Nutrition 1996, 63:791S-796S.
206. Olivieri O., Girelli D., Stanzial A.M., Rossi L., Bassi A., Corrocher R. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biological Trace Element Research 1996, 51:31-41.
207. Osaki S., Johnson D.A. Mobilization of liver iron by ferroxidase (ceruloplasmin). The Journal of Biological Chemistry 1969, 244:5757-5758.
208. Pagmantidis V., Meplan C., van Schothorst E.M., Keijer J., Hesketh J.E. Supplementation of healthy volunteers with nutritionally relevant amounts of selenium increases the expression of lymphocyte protein biosynthesis genes. The American Journal of Clinical Nutrition 2008, 87:181-189.
209. Pajonk F.G., Kessler H., Supprian T., Hamzei P., Bach D., Schweickhardt J., Herrmann W., Obeid R., Simons A., Falkai P., Multhaup G., Bayer T.A. Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. Journal of Alzheimer's Disease 2005, 8:23-27.
210. Pan Y., Loo G. Effect of copper deficiency on oxidative DNA damage in Jurkat T-lymphocytes. Free Radical Biology and Medicine 2000, 28:824-830.
211. Paolisso G., Barbieri M., Bonafe M., Franceschi C. Metabolic age modelling: the lesson from centenarians. European Journal of Clinical Investigation 2000, 30:888-894.
212. 2: a COX assembly gene. Nature Genetics 1999, 23:333-337.
213. Papp L.V., Lu J., Holmgren A., Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxidants and Redox Signaling 2007, 9:775-806.
214. Pearson R., Fleetwood J., Eaton S., Crossley M., Bao S. Kruppel-like transcription factors: a functional family. The International Journal of Biochemistry and Cell Biology 2008, 40:1996-2001.
215. Pena M.M., Puig S., Thiele D.J. Characterization of the Saccharomyces cerevisiae high affinity copper transporter Ctr3. The Journal of Biological Chemistry 2000, 275:33244-33251.
216. Pence B.C., Buddingh F. Effect of dietary selenium deficiency on incidence and size of 1,2-dimethylhydrazine-induced colon tumors in rats. The Journal of Nutrition 1985, 115:1196-1202.
217. Peretz A., Neve J., Desmedt J., Duchateau J., Dramaix M., Famaey J.P. Lymphocyte response is enhanced by supplementation of elderly subjects with selenium-enriched yeast. The American Journal of Clinical Nutrition 1991, 53:1323-1328.
218. Peters U., Chatterjee N., Hayes R.B., Schoen R.E., Wang Y., Chanock S.J., Foster C.B. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiology, Biomarkers and Prevention 2008, 17:1144-1154.
219. Petris M.J., Mercer J.F., Culvenor J.G., Lockhart P., Gleeson P.A., Camakaris J. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. The EMBO Journal 1996, 15:6084-6095.
220. Phinney A.L., Drisaldi B., Schmidt S.D., Lugowski S., Coronado V., Liang Y., Horne P., Yang J., Sekoulidis J., Coomaraswamy J., Chishti M.A., Cox D.W., Mathews P.M., Nixon R.A., Carlson G.A., St George-Hyslop P., Westaway D. In vivo reduction of amyloid-beta by a mutant copper transporter. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:14193-14198.
221. Powell S.R. The antioxidant properties of zinc. The Journal of Nutrition 2000, 130:1447S-1454S.
222. Prasad A.S. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. The Journal of Infectious Diseases 2000, 182(Suppl 1):S62-S68.
223. Prasad A.S. Zinc in human health: effect of zinc on immune cells. Molecular Medicine 2008, 14:353-377.
224. Prasad A.S. Discovery of human zinc deficiency: 50 years later. Journal of Trace Elements in Medicine and Biology 2012, 26:66-69.
225. Prasad A.S., Meftah S., Abdallah J., Kaplan J., Brewer G.J., Bach J.F., Dardenne M. Serum thymulin in human zinc deficiency. The Journal of Clinical Investigation 1988, 82:1202-1210.
226. Prasad A.S., Beck F.W., Bao B., Fitzgerald J.T., Snell D.C., Steinberg J.D., Cardozo L.J. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. The American Journal of Clinical Nutrition 2007, 85:837-844.
227. Prohaska J.R., Gybina A.A. Intracellular copper transport in mammals. The Journal of Nutrition 2004, 134:1003-1006.
228. Puig S., Thiele D.J. Molecular mechanisms of copper uptake and distribution. Current Opinion in Chemical Biology 2002, 6:171-180.
229. Quinn J.F., Crane S., Harris C., Wadsworth T.L. Copper in Alzheimer's disease: too much or too little?. Expert Review of Neurotherapeutics 2009, 9:631-637.
230. Raaschou-Nielsen O., Sorensen M., Hansen R.D., Frederiksen K., Tjonneland A., Overvad K., Vogel U. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Letters 2007, 247:293-300.
231. Ratnasinghe D., Tangrea J.A., Andersen M.R., Barrett M.J., Virtamo J., Taylor P.R., Albanes D. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Research 2000, 60:6381-6383.
232. Ravaglia G., Forti P., Maioli F., Bastagli L., Facchini A., Mariani E., Savarino L., Sassi S., Cucinotta D., Lenaz G. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged>=90 y. The American Journal of Clinical Nutrition 2000, 71:590-598.
233. Ray A.L., Semba R.D., Walston J., Ferrucci L., Cappola A.R., Ricks M.O., Xue Q.L., Fried L.P. Low serum selenium and total carotenoids predict mortality among older women living in the community: the women's health and aging studies. The Journal of Nutrition 2006, 136:172-176.
234. Rayman M.P. Selenium and human health. Lancet 2012, 379:1256-1268.
235. Reid M.E., Duffield-Lillico A.J., Garland L., Turnbull B.W., Clark L.C., Marshall J.R. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiology. Biomarkers and Prevention 2002, 11:1285-1291.
236. Reid M.E., Duffield-Lillico A.J., Sunga A., Fakih M., Alberts D.S., Marshall J.R. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. International Journal of Cancer 2006, 118:1777-1781.
237. Ridge P.G., Zhang Y., Gladyshev V.N. Comparative genomic analyses of copper transporters and cuproproteomes reveal evolutionary dynamics of copper utilization and its link to oxygen. PLoS ONE 2008, 3:e1378-e1391.
238. Rink L., Kirchner H. Zinc-altered immune function and cytokine production. The Journal of Nutrition 2000, 130:1407S-1411S.
239. Ritchie C.W., Bush A.I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R.E., Masters C.L. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Archives in Neurology 2003, 60:1685-1691.
240. Ross R. Atherosclerosis is an inflammatory disease. American Heart Journal 1999, 138:S419-S420.
241. Ryan-Harshman M., Aldoori W. The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases. Canadian Journal of Dietetic Practice and Research 2005, 66:98-102.
242. Saba I., Kosan C., Vassen L., Moroy T. IL-7R-dependent survival and differentiation of early T-lineage progenitors is regulated by the BTB/POZ domain transcription factor Miz-1. Blood 2011, 117:3370-3381.
243. Sahyoun N.R., Jacques P.F., Dallal G., Russell R.M. Use of albumin as a predictor of mortality in community dwelling and institutionalized elderly populations. Journal of Clinical Epidemiology 1996, 49:981-988.
244. Saltman P.D., Strause L.G. The role of trace minerals in osteoporosis. Journal of the American College of Nutrition 1993, 12:384-389.
245. Sandstead H.H. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. The American Journal of Clinical Nutrition 1995, 61(3 (Suppl)):621S-624S.
246. Sanz-Medel A., Montes-Bayon M., Luisa Fernandez Sanchez M. Trace element speciation by ICP-MS in large biomolecules and its potential for proteomics. Analytical and Bioanalytical Chemistry 2003, 377:236-247.
247. Savarino L., Granchi D., Ciapetti G., Cenni E., Ravaglia G., Forti P., Maioli F., Mattioli R. Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/centenarians. Experimental Gerontology 2001, 36:327-339.
248. Schomburg L., Schweizer U., Holtmann B., Flohe L., Sendtner M., Kohrle J. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. The Biochemical Journal 2003, 370:397-402.
249. Schwarz S. Essentiality and metabolic functions of selenium. The Medical Clinics of North America 1976, 60:745-758.
250. Seiler W.O. Clinical pictures of malnutrition in ill elderly subjects. Nutrition 2001, 17:496-498.
251. Seiler A., Schneider M., Forster H., Roth S., Wirth E.K., Culmsee C., Plesnila N., Kremmer E., Radmark O., Wurst W., Bornkamm G.W., Schweizer U., Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metabolism 2008, 8:237-248.
252. Semba R.D., Blaum C.S., Bartali B., Xue Q.L., Ricks M.O., Guralnik J.M., Fried L.P. Denture use, malnutrition, frailty, and mortality among older women living in the community. The Journal of Nutrition, Health and Aging 2006, 10:161-167.
253. Sensi S.L., Jeng J.M. Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. Current Molecular Medicine 2004, 4:87-111.
254. Sharif R., Thomas P., Zalewski P., Fenech M. The role of zinc in genomic stability. Mutation Research 2012, 733:111-121.
255. Sharif R., Thomas P., Zalewski P., Fenech M. Zinc deficiency or excess within the physiological range increases genome instability and cytotoxicity, respectively, in human oral keratinocyte cells. Genes and Nutrition 2012, 7:139-154.
256. Shibata T., Arisawa T., Tahara T., Ohkubo M., Yoshioka D., Maruyama N., Fujita H., Kamiya Y., Nakamura M., Nagasaka M., Iwata M., Takahama K., Watanabe M., Hirata I. Selenoprotein S (SEPS1) gene -105G>A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterology 2009, 9:230-239.
257. Shukla N., Maher J., Masters J., Angelini G.D., Jeremy J.Y. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?. Atherosclerosis 2006, 187:238-250.
258. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T.J., Montpetit A., Pshezhetsky A.V., Prentki M., Posner B.I., Balding D.J., Meyre D., Polychronakos C., Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
259. 2+ release. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:13952-13957.
260. Sparks D.L. Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain. Journal of Molecular Neuroscience 2004, 24:97-104.
261. Spencer N.F., Poynter M.E., Im S.Y., Daynes R.A. Constitutive activation of NF-kappa B in an animal model of aging. International Immunology 1997, 9:1581-1588.
262. Squitti R., Rossini P.M., Cassetta E., Moffa F., Pasqualetti P., Cortesi M., Colloca A., Rossi L., Finazzi-Agro A. d-Penicillamine reduces serum oxidative stress in Alzheimer's disease patients. European Journal of Clinical Investigation 2002, 32:51-59.
263. Stadler N., Lindner R.A., Davies M.J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:949-954.
264. Steveson T.C., Ciccotosto G.D., Ma X.M., Mueller G.P., Mains R.E., Eipper B.A. Menkes protein contributes to the function of peptidylglycine alpha-amidating monooxygenase. Endocrinology 2003, 144:188-200.
265. Stover P.J. Influence of human genetic variation on nutritional requirements. The American Journal of Clinical Nutrition 2006, 83:436S-442S.
266. Stranges S., Marshall J.R., Natarajan R., Donahue R.P., Trevisan M., Combs G.F., Cappuccio F.P., Ceriello A., Reid M.E. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Annals of Internal Medicine 2007, 147:217-223.
267. Suzuki K.T., Someya A., Komada Y., Ogra Y. Roles of metallothionein in copper homeostasis: responses to Cu-deficient diets in mice. Journal of Inorganic Biochemistry 2002, 88:173-182.
268. Swamynathan S.K. Kruppel-like factors: three fingers in control. Human Genomics 2010, 4:263-270.
269. Tang N.P., Wang L.S., Yang L., Gu H.J., Sun Q.M., Cong R.H., Zhou B., Zhu H.J., Wang B. Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population. Clinica Chimica Acta 2008, 395:89-93.
270. Tapia L., Gonzalez-Aguero M., Cisternas M.F., Suazo M., Cambiazo V., Uauy R., Gonzalez M. Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. The Biochemical Journal 2004, 378:617-624.
271. Toniato E., Chen X.P., Losman J., Flati V., Donahue L., Rothman P. TRIM8/GERP RING finger protein interacts with SOCS-1. The Journal of Biological Chemistry 2002, 277:37315-37322.
272. Tsaih S.W., Pezzolesi M.G., Yuan R., Warram J.H., Krolewski A.S., Korstanje R. Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan. Kidney International 2010, 77:201-210.
273. Turnlund J.R., Keyes W.R., Kim S.K., Domek J.M. Long-term high copper intake: effects on copper absorption, retention, and homeostasis in men. The American Journal of Clinical Nutrition 2005, 81:822-828.
274. Uciechowski P., Kahmann L., Plumakers B., Malavolta M., Mocchegiani E., Dedoussis G., Herbein G., Jajte J., Fulop T., Rink L. TH1 and TH2 cell polarization increases with aging and is modulated by zinc supplementation. Experimental Gerontology 2008, 43:493-498.
275. Ugarte M., Osborne N.N. Zinc in the retina. Progress in Neurobiology 2001, 64:219-249.
276. Underwood E.J. Trace metals in human and animal health. Journal of Human Nutrition 1981, 35:37-48.
277. Vallee B.L. The function of metallothionein. Neurochemistry International 1995, 27:23-33.
278. Ventura M.T., Serlenga E., Tortorella C., Antonaci S. In vitro vitamin E and selenium supplementation improves neutrophil-mediated functions and monocyte chemoattractant protein-1 production in the elderly. Cytobios 1994, 77:225-232.
279. Vinceti M., Solovyev N., Mandrioli J., Crespi C.M., Bonvicini F., Arcolin E., Georgoulopoulou E., Michalke B. Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology 2013, 38:25-32.
280. Visser M., Kritchevsky S.B., Newman A.B., Goodpaster B.H., Tylavsky F.A., Nevitt M.C., Harris T.B. Lower serum albumin concentration and change in muscle mass: the health, aging and body composition study. The American Journal of Clinical Nutrition 2005, 82:531-537.
281. Voetsch B., Jin R.C., Bierl C., Benke K.S., Kenet G., Simioni P., Ottaviano F., Damasceno B.P., Annichino-Bizacchi J.M., Handy D.E., Loscalzo J. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007, 38:41-49.
282. Walston J., Xue Q., Semba R.D., Ferrucci L., Cappola A.R., Ricks M., Guralnik J., Fried L.P. Serum antioxidants, inflammation, and total mortality in older women. American Journal of Epidemiology 2006, 163:18-26.
283. Wang P., Guliaev A.B., Hang B. Metal inhibition of human N-methylpurine-DNA glycosylase activity in base excision repair. Toxicology Letters 2006, 166:237-247.
284. Weiss J.H., Sensi S.L., Koh J.Y. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends in Pharmacological Sciences 2000, 21:395-401.
285. Wellinghausen N., Martin M., Rink L. Zinc inhibits interleukin-1-dependent T cell stimulation. European Journal of Immunology 1997, 27:2529-2535.
286. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., Richards R.I. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 1990, 8:513-518.
287. Windler E., Schoffauer M., Zyriax B.C. The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease. Diabetes and Vascular Disease Research 2007, 4:136-142.
288. Wong C.P., Ho E. Zinc and its role in age-related inflammation and immune dysfunction. Molecular Nutrition and Food Research 2012, 56:77-87.
289. Wood S.M., Beckham1 C., Yosioka2 A., Darban3 H., Watson R.R. beta-Carotene and selenium supplementation enhances immune response in aged humans. Integrative Medicine 2000, 2:85-92.
290. Yang S.W., Becker F.F., Chan J.Y. Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation. Environmental and Molecular Mutagenesis 1996, 28:19-25.
291. Yang K.C., Lee L.T., Lee Y.S., Huang H.Y., Chen C.Y., Huang K.C. Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutrition and Metabolism 2010, 7. 38-707-5-47.
292. Yetkin E., Waltenberger J. Molecular and cellular mechanisms of aortic stenosis. International Journal of Cardiology 2009, 135:4-13.
293. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Archives of Ophthalmology 2004, 122:598-614.